Malebo H M, Tanja W, Cal M, Swaleh S A M, Omolo M O, Hassanali A, Séquin U, Hamburger M, Brun R, Ndiege I O
National Institute for Medical Research, P.O. Box 9653, Dar es Salaam, Tanzania.
Tanzan J Health Res. 2009 Oct;11(4):226-34. doi: 10.4314/thrb.v11i4.50194.
The antiplasmodial, anti-trypanosomal and anti-leishmanial activity of 25 plant extracts obtained from seven Tanzanian medicinal plants: Annickia (Enantia) kummeriae (Annonaceae), Artemisia annua (Asteraceae), Pseudospondias microcarpa (Anacardiaceae), Drypetes natalensis (Euphorbiaceae), Acridocarpus chloropterus (Malpighiaceae), Maytenus senegalensis (Celastraceae) and Neurautanenia mitis (Papilonaceae), were evaluated in vitro against Plasmodium falciparum K1, Trypanosoma brucei rhodesiense STIB 900 and axenic Leishmania donovani MHOM-ET-67/82. Out of the 25 extracts tested, 17 showed good antiplasmodial activity (IC50 0.04-5.0 microg/ml), 7 exhibited moderate anti-trypanosomal activity (IC50 2.3-2.8 microg/ml), while 5 displayed mild anti-leishmanial activity (IC50 8.8-9.79 microg/ml). A. kummeriae, A. annua, P. microcarpa, D. natalensis, M. senegalensis and N. mitis extracts had good antiplasmodial activity (IC50 0.04-2.1 microg/ml) and selectivity indices (29.2-2,250 microg/ml). The high antiplasmodial, moderate anti-trypanosomal and mild anti-leishmanial activity make these plants good candidates for bioassay-guided isolation of anti-protozoal compounds which could serve as new lead structures for drug development.
对从七种坦桑尼亚药用植物中提取的25种植物提取物进行了抗疟原虫、抗锥虫和抗利什曼原虫活性评估,这七种植物分别是:安尼克木(Enantia)库默里(番荔枝科)、黄花蒿(菊科)、小果假槟榔青(漆树科)、纳塔尔核果木(大戟科)、绿翅辣木(金虎尾科)、塞内加尔美登木(卫矛科)和柔枝神经花(蝶形花科),评估是在体外针对恶性疟原虫K1、布氏罗得西亚锥虫STIB 900和无菌杜氏利什曼原虫MHOM-ET-67/82进行的。在测试的25种提取物中,17种显示出良好的抗疟原虫活性(半数抑制浓度[IC50]为0.04 - 5.0微克/毫升),7种表现出中等的抗锥虫活性(IC50为2.3 - 2.8微克/毫升),而5种表现出轻微的抗利什曼原虫活性(IC50为8.8 - 9.79微克/毫升)。库默里安尼克木、黄花蒿、小果假槟榔青、纳塔尔核果木、塞内加尔美登木和柔枝神经花的提取物具有良好的抗疟原虫活性(IC50为0.04 - 2.1微克/毫升)和选择性指数(29.2 - 2250微克/毫升)。这些植物具有高抗疟原虫、中等抗锥虫和轻微抗利什曼原虫活性,使其成为生物测定指导下分离抗原生动物化合物的良好候选者,这些化合物可作为药物开发的新先导结构。